Literature DB >> 2617198

Cancer risk in ulcerative colitis.

R G Farmer1.   

Abstract

Intestinal cancer may develop in patients with long-standing and extensive disease. This can occur in cases with either mild or severe inflammation. The development of cancer is usually preceded by dysplasia.

Entities:  

Mesh：

Year:  1989        PMID： 2617198     DOI： 10.1007/978-94-009-4269-1_15

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN： 0085-5928


  4 in total

Review 1.  Dysplasia and colitis.

Authors:  Robert Enns; Brian Bressler
Journal:  Can J Gastroenterol       Date:  2009-05       Impact factor: 3.522

2.  Incidence of and risk factors for dysplasia in mucosectomy area in ulcerative colitis patients undergoing restorative proctocolectomy.

Authors:  Ken Sagayama; Hiroki Ikeuchi; Takashi Nishigami; Hiroki Nakano; Motoi Uchino; Mitsuhiro Nakamura; Masafumi Noda; Hidenori Yanagi; Takehira Yamamura
Journal:  Int J Colorectal Dis       Date:  2006-08-26       Impact factor: 2.571

3.  Ulcerative colitis and coexisting colorectal cancer: recurrence rate after restorative proctocolectomy.

Authors:  Y Ziv; V W Fazio; S A Strong; J R Oakley; J W Milsom; I C Lavery
Journal:  Ann Surg Oncol       Date:  1994-11       Impact factor: 5.344

4.  Ropivacaine and lidocaine inhibit proliferation of non-transformed cultured adult human fibroblasts, endothelial cells and keratinocytes.

Authors:  T Martinsson; A Haegerstrand; C J Dalsgaard
Journal:  Agents Actions       Date:  1993-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.